Research ArticleBasic Science Investigations
Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of 131I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter
Anthony G. McCluskey, Robert J. Mairs, Mathias Tesson, Sally L. Pimlott, John W. Babich, Mark N. Gaze, Sue Champion and Marie Boyd
Journal of Nuclear Medicine July 2012, 53 (7) 1146-1154; DOI: https://doi.org/10.2967/jnumed.111.095943
Anthony G. McCluskey
Robert J. Mairs
Mathias Tesson
Sally L. Pimlott
John W. Babich
Mark N. Gaze
Sue Champion

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of 131I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter
Anthony G. McCluskey, Robert J. Mairs, Mathias Tesson, Sally L. Pimlott, John W. Babich, Mark N. Gaze, Sue Champion, Marie Boyd
Journal of Nuclear Medicine Jul 2012, 53 (7) 1146-1154; DOI: 10.2967/jnumed.111.095943
Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of 131I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter
Anthony G. McCluskey, Robert J. Mairs, Mathias Tesson, Sally L. Pimlott, John W. Babich, Mark N. Gaze, Sue Champion, Marie Boyd
Journal of Nuclear Medicine Jul 2012, 53 (7) 1146-1154; DOI: 10.2967/jnumed.111.095943